Cargando…
Anti-NMDA-R encephalitis: follow-up of 24 months
Anti-N-methyl-D-aspartate receptor (anti-NMDA-R) encephalitis is the second-most-common cause of autoimmune encephalitis, based on epidemiological studies.It has been predominantly described in young females, with prominent psychiatric symptoms, memory loss, decrease in level of consciousness, epile...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação de Neurologia Cognitiva e do
Comportamento
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619203/ https://www.ncbi.nlm.nih.gov/pubmed/29213855 http://dx.doi.org/10.1590/S1980-57642013DN70300012 |
_version_ | 1783267352756879360 |
---|---|
author | Soares, Emilia Maria Veloso Kauark, Roberta Borges Gomes Rocha, Maria Sheila Guimarães Brucki, Sonia Maria Dozzi |
author_facet | Soares, Emilia Maria Veloso Kauark, Roberta Borges Gomes Rocha, Maria Sheila Guimarães Brucki, Sonia Maria Dozzi |
author_sort | Soares, Emilia Maria Veloso |
collection | PubMed |
description | Anti-N-methyl-D-aspartate receptor (anti-NMDA-R) encephalitis is the second-most-common cause of autoimmune encephalitis, based on epidemiological studies.It has been predominantly described in young females, with prominent psychiatric symptoms, memory loss, decrease in level of consciousness, epilepsy, and central hypoventilation. The condition is commonly associated with mature ovarian teratomas. We describe a video report with a classic presentation of anti-NMDA-R encephalitis in a young patient with no identifiable tumor. Anti-NMDA encephalitis is a recognizable and treatable illness. The prognosis of patients depends on early diagnosis, implementation of appropriate immunomodulatory therapy and, in paraneoplastic cases, complete tumor removal. Clinicians should be wary of this condition, especially when assessing patients with recent onset of psychiatric symptoms unresponsive to antipsychotic treatment. |
format | Online Article Text |
id | pubmed-5619203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Associação de Neurologia Cognitiva e do
Comportamento |
record_format | MEDLINE/PubMed |
spelling | pubmed-56192032017-12-06 Anti-NMDA-R encephalitis: follow-up of 24 months Soares, Emilia Maria Veloso Kauark, Roberta Borges Gomes Rocha, Maria Sheila Guimarães Brucki, Sonia Maria Dozzi Dement Neuropsychol Case Reports Anti-N-methyl-D-aspartate receptor (anti-NMDA-R) encephalitis is the second-most-common cause of autoimmune encephalitis, based on epidemiological studies.It has been predominantly described in young females, with prominent psychiatric symptoms, memory loss, decrease in level of consciousness, epilepsy, and central hypoventilation. The condition is commonly associated with mature ovarian teratomas. We describe a video report with a classic presentation of anti-NMDA-R encephalitis in a young patient with no identifiable tumor. Anti-NMDA encephalitis is a recognizable and treatable illness. The prognosis of patients depends on early diagnosis, implementation of appropriate immunomodulatory therapy and, in paraneoplastic cases, complete tumor removal. Clinicians should be wary of this condition, especially when assessing patients with recent onset of psychiatric symptoms unresponsive to antipsychotic treatment. Associação de Neurologia Cognitiva e do Comportamento 2013 /pmc/articles/PMC5619203/ /pubmed/29213855 http://dx.doi.org/10.1590/S1980-57642013DN70300012 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Soares, Emilia Maria Veloso Kauark, Roberta Borges Gomes Rocha, Maria Sheila Guimarães Brucki, Sonia Maria Dozzi Anti-NMDA-R encephalitis: follow-up of 24 months |
title | Anti-NMDA-R encephalitis: follow-up of 24 months |
title_full | Anti-NMDA-R encephalitis: follow-up of 24 months |
title_fullStr | Anti-NMDA-R encephalitis: follow-up of 24 months |
title_full_unstemmed | Anti-NMDA-R encephalitis: follow-up of 24 months |
title_short | Anti-NMDA-R encephalitis: follow-up of 24 months |
title_sort | anti-nmda-r encephalitis: follow-up of 24 months |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619203/ https://www.ncbi.nlm.nih.gov/pubmed/29213855 http://dx.doi.org/10.1590/S1980-57642013DN70300012 |
work_keys_str_mv | AT soaresemiliamariaveloso antinmdarencephalitisfollowupof24months AT kauarkrobertaborgesgomes antinmdarencephalitisfollowupof24months AT rochamariasheilaguimaraes antinmdarencephalitisfollowupof24months AT bruckisoniamariadozzi antinmdarencephalitisfollowupof24months |